Compare VNRX & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | JCSE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | Singapore |
| Employees | 75 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 7.8M |
| IPO Year | 2012 | 2022 |
| Metric | VNRX | JCSE |
|---|---|---|
| Price | $0.25 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.67 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 6.1K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 8.18% |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $355.66 | N/A |
| Revenue Next Year | $849.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $0.77 |
| 52 Week High | $3.26 | $2.50 |
| Indicator | VNRX | JCSE |
|---|---|---|
| Relative Strength Index (RSI) | 29.22 | 47.46 |
| Support Level | $0.22 | $1.32 |
| Resistance Level | $0.27 | $1.45 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 24.28 | 26.37 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.